Comparison of the proteome of isoniazid-resistant and -susceptible strains of Mycobacterium tuberculosis

Microbial Drug Resistance

Volumn 12, Issue 4, 2006, Pages 231-238

  Jiang, Xin ^a,e   Zhang, Wenhong ^b,d   Gao, Feng ^c   Huang, Yishu ^a   Lv, Chong ^a   Wang, Honghai ^a,f  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY   (China)

^d UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^e SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^f FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; MEMBRANE PROTEIN; PROTEOME;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SERODIAGNOSIS;

GENOME, BACTERIAL; ISONIAZID; MYCOBACTERIUM TUBERCULOSIS; PROTEOME; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUBERCULOSIS, MULTIDRUG-RESISTANT;

MYCOBACTERIUM TUBERCULOSIS;

EID: 33846233910     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/mdr.2006.12.231     Document Type: Article

References (24)

1. Bahk, Y.Y., S.A. Kim, J.S. Kim, H.J. Euh, G.H. Bai, S.N. Cho, and Y.S. Kim. 2004. Antigens secreted from Mycobacterium tuberculosis: identification by proteomics approach and test for diagnostic marker. Proteomics. 11:3299-3307.
2. Barlow, R.E.L., D.M. Gascoyne-Binzi, S.H. Gillespie, A. Dickens, S. Qamer, and P.M. Hawkey. 2001. Comparison of variable number tandem repeat and IS6110-restriction fragment length polymorphism analyses for discrimination of high- and low-copy-number IS6110 Mycobacterium tuberculosis isolates. J. Clin. Microbiol. 39:2453-2457.
3. Betts, J.C., P. Dodson, S. Quan, A.P. Lewis, P.J. Thomas, K. Duncan, and R.A. McAdam. 2000. Comparison of the proteome of Mycobacterium tuberculosis strain H37Rv with clinical isolate CDC 1551. Microbiology 146:3205-3216.
4. Cole, S.T., R. Brosch, J. Parkhill, T. Garnier, C. Churcher, D. Harris, S.V. Gordon, K. Eiglmeier, S. Gas, C.E. Barry III, F. Tekaia, K. Badcock, D. Basham, D. Brown, T. Chillingworth, R. Connor, R. Davies, K. Devlin, T. Feltwell, S. Gentles, N. Hamlin, S. Holroyd, T. Hornsby, K. Jagels, A. Krogh, J. McLean, S. Moule, L. Murphy, K. Oliver, J. Osborne, M.A. Quail, M.-A. Rajandream, J. Rogers, S. Rutter, K. Seeger, J. Skelton, R. Squares, S. Squares, J.E. Sulston, K. Taylor, S. Whitehead, and B.G. Barrell. 1998. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393:537-544.
5. Espase, M., J. Gonzalez-Martin, F. Alcaide, L.M. Aragon, J. Lonca, J.M. Manterola, M. Salvado, G. Tudo, P. Orus, and P. Coll. 2005. Direct detection in clinical samples of multiple gene mutations causing resistance of Mycobacterium tuberculosis to isoniazid and rifampicin using fluorogenic probes. J. Antimicrob. Chemother. 55:860-865.
6. Gharahdaghi, F., C.R. Weinberg, D.A. Meagher, B.S. Imai, and S.M. Mische. 1999. Mass spectrometric identification of proteins from silver-stained polyacylamide gel: a method for the removal of silver ions to enhance sensitivity. Electrophoresis 20:601-605.
7. Gonzales-Merchand, J.A., I. Estrada-Garcia, M.J. Coston, and R.A. Cox. 1996. A novel method for the isolation of mycobacterial DNA. FEMS Microbiol. 135:71-77.
8. Gu, S., J. Chen, K.M. Dobos, E.M. Bradbury, J.T. Belisle, and X. Chen. 2003. Comprehensive proteomic profiling of the membrane constituents of a Mycobacterium tuberculosis strain. Mol. Cel. Proteomics. 2:1284-1296.
9. Jungblut, P.R., E.C. Muller, J. Mattow, and S.H. Kaufmann. 2001. Proteomics reveals open reading frames in Mycobacterium tuberculosis H37Rv nit predicted by genomics. Infect. Immun. 69:5905-5970.
10. Kang, C., D.W. Abbott, S.T. Park, C.C. Dascher, L.C. Cantley, and R.N. Husson. 2005. The Mycobacterium tuberculosis serine/threonine kinases PknA and PknB: substrate identification and regulation of cell shape. Genes Dev. 19:1692-1704.
11. Kox, L.F., G.T. Noordhoek, M. Kunakorn, S. Mulder, M. Sterrenburg, and A.H. Kolk. 1996. Microwell hybridization assay for detection of PCR products from Mycobacterium tuberculosis complex and the recombinant Mycobacterium smegmatis strain 1008 used as an internal control. J. Clin. Microbiol. 34:2117-2120.
12. Mattow, J., P.R. Jungblut, E.C. Muller, and S.H. Kaufmann. 2001. Identification of acidic, low molecular mass proteins of Mycobacterium tuberculosis strain H37Rv by matrix-assisted laser desorption/ionization and electrospray ionization mass spectrometry. Proteomics 1:494-507.
13. Mollenkopf, H.J., L. Grode, J. Mattow, M. Stein, P. Mann, B. Knapp, J. Ulmer, and S.H.E. Kaufmann. 2004. Application of mycobacterial proteomics to vaccine design: Improved protection by Mycobacterium bovis BCG Prime-Rv3407 DNA boost vaccination against tuberculosis. Infect. Immun. 72:6471-6479.
14. Niemann, S., E. Richter, and S. Rüsch-Gerdes. 1999. Stability of Mycobacterium tuberculosis IS6110 restriction fragment length polymorphism patterns and spoligotypes determined by analyzing serial isolates from patients with drug-resistant tuberculosis. J. Clin. Microbiol. 37:409-412.
15. Parish, T., D.A. Smith, G. Roberts, J. Betts, and N.G. Stoker. 2003. The senX3-regX3 two-component regulatory system of Mycobacterium tuberculosis is required for virulence. Microbiology 149:1423-1435.
16. Ramaswamy, S.V., R. Reich, S.J. Dou, L. Jasperse, X. Pan, A. Wanger, T. Quitugua, and E.A. Graviss. 2003. Single nucleotide polymorphisms in genes associated with isoniazid resistance in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 47:1241-1250.
17. Rawat, R., A. Whitty, and P.J. Tonge. 2003. The isoniazid-NAD adduct is a slow, tight-binding inhibitor of InhA, the Mycobacterium tuberculosis enoyl reductase: adduct affinity and drug resistance. Proc. Natl. Acad. Sci. USA 100:13881-13886.
18. Sassetti, C.M., D.H. Boyd, and E.J. Rubin. 2003. Genes required for mycobacterial growth defined by high density mutagenesis. Mol. Microbiol. 48:77-84.
19. Scheler, C., S. Lamer, Z. Pan, X.P. Li, J. Salnikow, and P. Jungblut. 1998. Peptide mass fingerprint sequence coverage from differentially stained proteins on 2-DE patterns by MALDI-MS. Electrophoresis 19:918-927.
20. Schmid, F., S. Donahoe, K. Hagens, J. Mattow, U.E. Schaible, S.H.E. Kaufmann, and R. Aebersold. 2004. Complementary analysis of the Mycobacterium tuberculosis proteome by two-dimensional electrophoresis and isotope-coded affinity tag technology. Mol. Cel. Proteomics. 3:23-42.
21. Wadw, M.M., and Y. Zhang. 2004. Mechanisms of drug resistance in Mycobacterium tuberculosis. Front. Biosci. 9:975-994.
22. World Health Organization. 2003. Global tuberculosis control: surveillance, planning, and finacing. Geneva: WHO, WHO/CDS/TB.316-319.
23. Zhang, Y., B. Heym, B. Allen, D. Young, and S. Cole. 1992. The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature 358:591-593.
24. Zhang, Y., and A. Telenti. 2000. Genetics of drug resistance in Mycobacterium tuberculosis. In Molecular genetics of mycobacteria. ASM Press, Washington D.C., pp. 235-254.